Delhi HC issues notice to NBE, Centre over DNB Revaluation clause challenge We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Health Bulletin 30/August/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Mankind Pharma Wins PETKIND Trademark Battle, Court Orders Journal Advertisement Within Two Months We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
HC notice to Centre on plea against NMC allowing medical MSc, PhD faculty in MBBS We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Health Bulletin 22/August/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Delhi HC seeks Centre’s response on plea against NMC allowing Medical MSc, PhD faculty in MBBS We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Doctors Challenge NMC Regulations Allowing medical MSc, PhD holders as Faculty in core MBBS subjects We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
MUMBAI: Hyderabad-based Natco Pharma has sued Danish drugmaker Novo Nordisk, maker of blockbuster weight-loss drug Wegovy (semaglutide), claiming its version of the drug does not infringe upon the device or process patent technology owned by the multinational company. The case came up for hearing in Delhi High Court on Wednesday. “The court has directed the…
150 MBBS, 49 PG seats restored at Hamdard Institute of Medical Sciences and Research, Affiliation row settled We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link